|
|
Article: Tryton Medical Receives CE Mark Approval for its Side-Branch Stent.
- Article from:
- PR Newswire
- Article date:
- February 4, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Tryton's revolutionary Side Branch Stent obtains CE Mark approval based on unprecedented results in the Tryton 1 (First-in-Man Study) with No Side-Branch Restenosis in 30 patients.
NEWTON, Mass., Feb. 4 /PRNewswire/ -- Tryton Medical, Inc., the leading developer of stents designed for the definitive treatment bifurcation lesions announced that the company has received CE Mark approval for its Side Branch Stent. The Tryton Side-Branch Stent is a high performance cobalt chromium balloon-expandable coronary stent specifically developed for the complete treatment of the entire spectrum of coronary artery bifurcation disease. Approximately 540,000 annual procedures ...
Related newspaper, magazine, and journal articles:
|
|
Article: Tryton Medical, Inc. Broadcasts Successful Live ...
Business Wire;
September 24, 2009 ;
700+ words
... ... main vessel. The Tryton Side Branch Stent System demonstrated excellent ... the United States. About Tryton Medical, Inc. Tryton Medical, Inc., located in Durham ... lesions. The company`s Side Branch Stent System, approved for sale ...
|
|